Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomohisa Kawakami

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Sensors (Basel, Switzerland)|November 14, 2023
A Deep Reinforcement Learning Approach to Droplet Routing for Erroneous Digital Microfluidic BiochipsTomohisa Kawakami, Chiharu Shiro, Hiroki Nishikawa, et al.
Investigational New Drugs|July 2, 2016
Phase I dose-finding study of monotherapy with atezolizumab, an engineered immunoglobulin monoclonal antibody targeting PD-L1, in Japanese patients with advanced solid tumorsHidenori Mizugaki, Noboru Yamamoto, Haruyasu Murakami, et al.
Plos One|January 14, 2022
Cell behaviors within a confined adhesive area fabricated using novel micropatterning methodsTsukasa Nakatoh, Takuji Osaki, Sohma Tanimoto, et al.
Clinical Lung Cancer|August 31, 2019
Subgroup Analysis of Japanese Patients in a Phase III Study of Atezolizumab in Extensive-stage Small-cell Lung Cancer (IMpower133)Makoto Nishio, Shunichi Sugawara, Shinji Atagi, et al.
Clinical Lung Cancer|March 12, 2018
Atezolizumab in Japanese Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer: A Subgroup Analysis of the Phase 3 OAK StudyToyoaki Hida, Reiko Kaji, Miyako Satouchi, et al.
Cancer Science|January 19, 2021
IMpower132: Atezolizumab plus platinum-based chemotherapy vs chemotherapy for advanced NSCLC in Japanese patientsMakoto Nishio, Haruhiro Saito, Koichi Goto, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Sensors (Basel, Switzerland)|November 14, 2023
A Deep Reinforcement Learning Approach to Droplet Routing for Erroneous Digital Microfluidic BiochipsTomohisa Kawakami, Chiharu Shiro, Hiroki Nishikawa, et al.
Investigational New Drugs|July 2, 2016
Phase I dose-finding study of monotherapy with atezolizumab, an engineered immunoglobulin monoclonal antibody targeting PD-L1, in Japanese patients with advanced solid tumorsHidenori Mizugaki, Noboru Yamamoto, Haruyasu Murakami, et al.
Plos One|January 14, 2022
Cell behaviors within a confined adhesive area fabricated using novel micropatterning methodsTsukasa Nakatoh, Takuji Osaki, Sohma Tanimoto, et al.
Clinical Lung Cancer|August 31, 2019
Subgroup Analysis of Japanese Patients in a Phase III Study of Atezolizumab in Extensive-stage Small-cell Lung Cancer (IMpower133)Makoto Nishio, Shunichi Sugawara, Shinji Atagi, et al.
Clinical Lung Cancer|March 12, 2018
Atezolizumab in Japanese Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer: A Subgroup Analysis of the Phase 3 OAK StudyToyoaki Hida, Reiko Kaji, Miyako Satouchi, et al.
Cancer Science|January 19, 2021
IMpower132: Atezolizumab plus platinum-based chemotherapy vs chemotherapy for advanced NSCLC in Japanese patientsMakoto Nishio, Haruhiro Saito, Koichi Goto, et al.
Pageof 1